Glutamine deprivation induces interleukin-8 expression in ataxia telangiectasia fibroblasts

Inflammation Research

Volumn 63, Issue 5, 2014, Pages 347-356

  Kim, Min Hyun ^a   Kim, Aryung ^a   Yu, Ji Hoon ^a   Lim, Joo Weon ^a   Kim, Hyeyoung ^a  

^a Yonsei University   (South Korea)

Author keywords

Ataxia telangiectasia; Glutamine; Interleukin 8; Reactive oxygen species

Indexed keywords

ATM PROTEIN; CATALASE; COMPLEMENTARY DNA; GLUTAMINE; GLUTATHIONE; HYDROGEN PEROXIDE; INTERLEUKIN 8; KERATINOCYTE DERIVED CHEMOKINE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SMALL INTERFERING RNA; ATM PROTEIN, HUMAN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ARTICLE; ATAXIA TELANGIECTASIA; COLORIMETRY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EMBRYO; ENZYMATIC ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENCE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELLS, CULTURED; DNA; FIBROBLASTS; GLUTAMINE; GLUTATHIONE; HUMANS; INTERLEUKIN-8; MICE; NF-KAPPA B; REACTIVE OXYGEN SPECIES;

EID: 84899647478     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0706-0     Document Type: Article

References (41)

1. Meyn MS. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 1995;55:5991-6001.
2. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268:1749-53.
3. Lee JH, Kim KH, Morio T, Kim H. Ataxia-telangiectasia-mutated-dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide. Ann N Y Acad Sci. 2006;1091:76-82. (Pubitemid 47092226)
4. Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, Rotman G, Barzilai A. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 2001;61:1849-54. (Pubitemid 32691998)
5. Perry JJ, Tainer JA. All stressed out without ATM kinase. Sci Signal. 2011;4:pe18.
6. Liu N, Stoica G, Yan M, Scofield VL, Qiang W, Lynn WS, Wong PK. ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab Invest. 2005;85:1471-80. (Pubitemid 41662332)
7. Reichenbach J, Schubert R, Schwan C, Muller K, Bohles HJ, Zielen S. Anti-oxidative capacity in patients with ataxia telangiectasia. Clin Exp Immunol. 1999;117:535-9. (Pubitemid 29398302)
8. Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst). 2002;1:3-25. (Pubitemid 34475690)
9. McKinnon PJ. ATM and ataxia telangiectasia. EMBO Rep. 2004;5:772-6.
10. McGrath-Morrow SA, Collaco JM, Crawford TO, Carson KA, Lefton-Greif MA, Zeitlin P, Lederman HM. Elevated serum IL-8 levels in ataxia telangiectasia. J Pediatr. 2010;156(682-4):e1.
11. Fan YP, Yu JC, Kang WM, Zhang Q. Effects of glutamine supplementation on patients undergoing abdominal surgery. Chin Med Sci J. 2009;24:55-9.
12. Roth E. Nonnutritive effects of glutamine. J Nutr. 2008;138:2025S-31S.
13. Kim H. Glutamine as an immunonutrient. Yonsei Med J. 2011;52(6):892-7.
14. Liboni KC, Li N, Scumpia PO, Neu J. Glutamine modulates LPS-induced IL-8 production through IkappaB/NF-kappaB in human fetal and adult intestinal epithelium. J Nutr. 2005;135:245-51. (Pubitemid 40194486)
15. Coeffier M, Marion R, Leplingard A, Lerebours E, Ducrotte P, Dechelotte P. Glutamine decreases interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins e(2) production by human gut in vitro. Cytokine. 2002;18:92-7. (Pubitemid 34754099)
16. Coeffier M, Miralles-Barrachina O, Le Pessot F, Lalaude O, Daveau M, Lavoinne A, Lerebours E, Déchelotte P. Influence of glutamine on cytokine production by human gut in vitro. Cytokine. 2001;13:148-54. (Pubitemid 32579303)
17. Liboni K, Li N, Neu J. Mechanism of glutamine-mediated amelioration of lipopolysaccharide-induced IL-8 production in Caco-2 cells. Cytokine. 2004;26:57-65. (Pubitemid 38410884)
18. Huang Y, Li N, Liboni K, Neu J. Glutamine decreases lipopolysaccharide- induced IL-8 production in Caco-2 cells through a non-NF-kappaB p50 mechanism. Cytokine. 2003;22:77-83. (Pubitemid 36808765)
19. Chu CC, Hou YC, Pai MH, Chao CJ, Yeh SL. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis. J Nutr Biochem. 2012;23:1092-9.
20. Remick DG. Interleukin-8. Crit Care Med. 2005;33:S466-7. (Pubitemid 41785990)
21. Ghasemi H, Ghazanfari T, Yaraee R, Faghihzadeh S, Hassan ZM. Roles of IL-8 in ocular inflammations: a review. Ocul Immunol Inflamm. 2011;19:401-12.
22. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002;72:847-55. (Pubitemid 35365158)
23. Presnell CE, Bhatti G, Numan LS, Lerche M, Alkhateeb SK, Ghalib M, Shammaa M, Kavdia M. Computational insights into the role of glutathione in oxidative stress. Curr Neurovasc Res. 2013;10:185-94.
24. Takagi M, Tsuchida R, Oguchi K, Shigeta T, Nakada S, Shimizu K, Ohki M, Delia D, Chessa L, Taya Y, Nakanishi M, Tsunematsu Y, Bessho F, Isoyama K, Hayashi Y, Kudo K, Okamura J, Mizutani S. Identification and characterization of polymorphic variations of the ataxia telagiectasia mutated (ATM) gene in childhood Hodgkin disease. Blood. 2004;103:283-90. (Pubitemid 38029950)
25. Shiratori Y, Hikiba Y, Mawet E, Niwa Y, Matsumura M, Kato N, Shiina S, Tada M, Komatsu Y, Kawabe T, Yoshida H, Okano K, Omata M. Modulation of KC/gro protein (interleukin-8 related protein in rodents) release from hepatocytes by biologically active mediators. Biochem Biophys Res Commun. 1994;203: 1398-403.
26. Jang SH, Lim JW, Morio T, Kim H. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells. Free Rad Biol Med. 2012;52:607-15.
27. Jang SH, Lim JW, Kim H. Mechanism of beta-carotene-induced apoptosis of gastric cancer cells: involvement of ataxia-telangiectasia-mutated. Ann N Y Acad Sci. 2009;1171:156-62.
28. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502-22.
29. Kim H, Kim KH. Effect of nitroc oxide on hydrogen peroxide-induced damage in isolated rabbit gastric glands. Pharmacology. 1998;57:323-30. (Pubitemid 28510969)
30. Thurman RG, Ley HG, Scholz R. Hepatic microsomal ethanol oxidation. Eur J Biochem. 1972;25:420-30.
31. Humbert B, Nguyen P, Martin L, Dumon H, Vallette G, Maugere P, Darmaun D. Effect of glutamine on glutathione kinetics in vivo in dogs. J Nutr Biochem. 2007;18:10-6. (Pubitemid 44827714)
32. Todorova VK, Harms SA, Kaufmann Y, Luo S, Luo KQ, Babb K, Klimberg VS. Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats. Breast Cancer Res Treat. 2004;88:247-56. (Pubitemid 40137303)
33. Oehler R, Roth E. Regulative capacity of glutamine. Curr Opin Clin Nutr Metab Care. 2003;6:277-82. (Pubitemid 40684603)
34. Guerin PJ, Furtak T, Eng K, Gauthier ER. Oxidative stress is not required for the induction of apoptosis upon glutamine starvation of Sp2/0-Ag14 hybridoma cells. Eur J Cell Biol. 2006;85:355-65.
35. Ambrose M, Gatti RA. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood. 2013;121:4036-45.
36. Quick KL, Dugan LL. Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia. Ann Neurol. 2001;49:627-35. (Pubitemid 32429789)
37. Barlow C, Dennery PA, Shigenaga MK, Smith MA, Morrow JD, Roberts LJ 2nd, Wynshaw-Boris A, Levine RL. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci USA. 1999;96:9915-9. (Pubitemid 29398832)
38. D'Souza AD, Parish IA, Krause DS, Kaech SM, Shadel GS. Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia. Mol Ther. 2013;21:42-8.
39. Hoche F, Seidel K, Theis M, Vlaho S, Schubert R, Zielen S, Kieslich M. Neurodegeneration in ataxia telangiectasia: what is new? What is evident? Neuropediatrics. 2012;43:119-29.
40. O'Riordain MG, De Beaux A, Fearon KC. Effect of glutamine on immune function in the surgical patient. Nutrition. 1996;12:S82-4. (Pubitemid 26427560)
41. Lu CY, Shih YL, Sun LC, Chuang JF, Ma CJ, Chen FM, Wu DC, Hsieh JS, Wang JY. The inflammatory modulation effect of glutamine-enriched total parenteral nutrition in postoperative gastrointestinal cancer patients. Am Surg. 2011;77:59-64.